The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Category: Insurance
Patients Suffer When Health Care Behemoths Quarrel Over Contracts
The latest example is Sutter Health and Anthem Blue Cross, whose failure to seal a deal is causing Anthem members to worry they may not have access to one of the dominant hospital chains in Northern California. Across the U.S., the stakes in such contract fights have risen, as health systems and insurers battle to increase their market share.
Nonprofit Dental Insurer Under Scrutiny For ‘Flagrant’ Spending
Delta Dental of California, with more than 36 million enrollees across the country, is looking to buy a stake in a for-profit insurance company based in Oregon. Consumer advocates are calling on regulators to scrutinize the transaction, arguing that it is just the latest questionable move by the nonprofit dental insurer whose corporate practices may be out of step with its tax-exempt status.
Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
New Covered California Sign-Ups Plummet
New enrollment in Covered California plans plunged by nearly a quarter this year compared with last year, posting a bigger drop than the federal health insurance exchange, healthcare.gov, which saw a 16 percent decrease. Officials largely blame the elimination of the tax penalty for people without insurance.
Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.